Clinical Trial Update: Placebo Controlled Study to Assess the Efficacy and Safety of Rapamycin in Drug Resistant Epilepsy Associated With Tuberous Sclerosis Complex [Phase 3]

View source ↗

Summary

A Phase 3 placebo-controlled trial evaluating rapamycin for drug-resistant epilepsy in tuberous sclerosis complex is recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Tuberous Sclerosis Complex

Drugs mentioned

• Rapamycin (sirolimus)

Snippet

Sponsor: Katarzyna Kotulska | Conditions: Tuberous Sclerosis Complex | Phase 3 | Status: RECRUITING